Clinical Trial · NCT05538676

Fluoride-labeled Boronophenylalanine PET Imaging in Patients With Solid Tumors

Overview

Recently, new high-dose radiation therapy \[e.g., boron neutron capture therapy (BNCT)\] absorbed into the tumor tissue has been applied to treat patients with solid tumors. Here we examine and describe how to evaluate the biological activity of tumors using positron emission tomography (PET) with fluoride-labeled boronophenylalanine (F-BPA) as a tracer.

Sponsor

Tongji Hospital

ClinicalTrials.gov

NCT05538676

Drug / Compound

BPA

Isotope(s):

Target(s):

Amino Acid Transport

Ligand Class: Small Molecules

Eligibility

Inclusion

Inclusion criteria not yet provided.

Exclusion

Pregnant women; renal failure (serum Cr\>3mg/dl); Patients with claustrophobia;